1. Home
  2. CRBU vs RMBI Comparison

CRBU vs RMBI Comparison

Compare CRBU & RMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • RMBI
  • Stock Information
  • Founded
  • CRBU 2011
  • RMBI 1887
  • Country
  • CRBU United States
  • RMBI United States
  • Employees
  • CRBU N/A
  • RMBI N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • RMBI Major Banks
  • Sector
  • CRBU Health Care
  • RMBI Finance
  • Exchange
  • CRBU Nasdaq
  • RMBI Nasdaq
  • Market Cap
  • CRBU 165.8M
  • RMBI 140.3M
  • IPO Year
  • CRBU 2021
  • RMBI 2019
  • Fundamental
  • Price
  • CRBU $1.72
  • RMBI $14.42
  • Analyst Decision
  • CRBU Strong Buy
  • RMBI
  • Analyst Count
  • CRBU 3
  • RMBI 0
  • Target Price
  • CRBU $6.67
  • RMBI N/A
  • AVG Volume (30 Days)
  • CRBU 656.9K
  • RMBI 16.1K
  • Earning Date
  • CRBU 11-05-2025
  • RMBI 10-23-2025
  • Dividend Yield
  • CRBU N/A
  • RMBI 4.11%
  • EPS Growth
  • CRBU N/A
  • RMBI 17.64
  • EPS
  • CRBU N/A
  • RMBI 0.95
  • Revenue
  • CRBU $9,121,000.00
  • RMBI $43,502,862.00
  • Revenue This Year
  • CRBU $9.23
  • RMBI N/A
  • Revenue Next Year
  • CRBU N/A
  • RMBI N/A
  • P/E Ratio
  • CRBU N/A
  • RMBI $15.36
  • Revenue Growth
  • CRBU N/A
  • RMBI 4.48
  • 52 Week Low
  • CRBU $0.66
  • RMBI $11.37
  • 52 Week High
  • CRBU $3.00
  • RMBI $15.15
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 42.15
  • RMBI 49.27
  • Support Level
  • CRBU $1.78
  • RMBI $14.33
  • Resistance Level
  • CRBU $1.94
  • RMBI $14.66
  • Average True Range (ATR)
  • CRBU 0.11
  • RMBI 0.35
  • MACD
  • CRBU -0.02
  • RMBI -0.04
  • Stochastic Oscillator
  • CRBU 1.33
  • RMBI 46.37

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About RMBI Richmond Mutual Bancorporation Inc.

Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.

Share on Social Networks: